Entering text into the input field will update the search result below

Abbott Labs spin-off AbbVie (NYSE:ABBV) forecasts 2013 earnings in line with consensus,...

Jan. 30, 2013 8:42 AM ETAbbVie Inc. (ABBV) StockABBVBy: Yigal Grayeff, SA News Editor
Abbott Labs spin-off AbbVie (NYSE:ABBV) forecasts 2013 earnings in line with consensus, predicting adjusted EPS of $3.03-$3.13 vs estimates of $3.08. AbbVie expects its growth to be driven by new treatments for illnesses that have a high unmet need.

Recommended For You

More Trending News

About ABBV Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ABBV--
AbbVie Inc.